文献速递流行病学与生物统计临床试验与 GCP

在优效性临床试验中利用混合经典与贝叶斯程序确定二分类反应的样本量

Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
PubMed 文献 · Trials · 2017-02-23

本文提出一种混合经典与贝叶斯程序,将π1和π2的先验分布正式整合入研究功效计算,采用条件期望功效(CEP)求样本量,使预设频率学派功效与CEP相等。模拟场景显示,当参数存在不确定性时,CEP设计比基于点估计的传统设计更一致稳健,传统样本量计算倾向于低估所需样本量。当参数不确定性不大时,该方法边际获益最大。

要点

  • 提出混合经典与贝叶斯程序,将π1和π2的先验分布整合入功效计算。
  • 采用条件期望功效(CEP)求样本量,使预设频率学派功效与CEP相等。
  • 参数存在不确定性时,CEP设计比传统点估计设计更一致稳健。

核心结论

  • 通过该程序可将研究参数不确定性和变异性的先验信息正式整合入研究设计,同时保持频率学派框架用于最终分析。
  • 求解达到高CEP所需样本量有助于防止假设治疗效应错误指定,并提供有依据的估计作为设计阶段讨论研究可行性的基础。

研究设计与样本

  • 本文提出一种混合经典与贝叶斯程序,将π1和π2分布的先验信息正式整合入研究功效计算。
  • 采用条件期望功效(CEP),以π1和π2的先验分布为平均权重、在存在阳性治疗效应(即π2>π1)条件下对传统功效曲线进行平均,并求使预设频率学派功效(1-β)与试验CEP相等的样本量。
  • 通过名义场景评估比较基于传统功效的试验设计与基于CEP的设计达到目标功效值的概率。

主要发现

  • 若研究参数存在不确定性且π1和π2有合理值分布,CEP设计的性能比基于研究参数点估计的传统设计更一致、更稳健。
  • 基于假设研究参数点估计的传统样本量计算倾向于低估考虑参数不确定性所需的样本量。
  • 所提方法的最大边际获益在参数不确定性不大时实现。

临床怎么用

  • 作者认为,通过该程序可将研究参数不确定性和变异性的先验信息正式整合入研究设计,同时保持频率学派框架用于最终分析。
  • 作者认为,求解达到高CEP所需样本量有助于防止假设治疗效应错误指定,并提供有依据的估计作为设计阶段讨论研究可行性的基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When designing studies that have a binary outcome as the primary endpoint, the hypothesized proportion of patients in each population experiencing the endpoint of interest (i.e., π 1,π 2) plays an important role in sample size and power calculations. Point estimates for π 1 and π 2 are often calculated using historical data. However, the uncertainty in these estimates is rarely addressed. METHODS: This paper presents a hybrid classical and Bayesian procedure that formally integrates prior information on the distributions of π 1 and π 2 into the study's power calculation. Conditional expected power (CEP), which averages the traditional power curve using the prior distributions of π 1 and π 2 as the averaging weight conditional on the presence of a positive treatment effect (i.e., π 2>π 1), is used, and the sample size is found that equates the pre-specified frequentist power (1-β) and the conditional expected power of the trial. RESULTS: Notional scenarios are evaluated to compare the probability of achieving a target value of power with a trial design based on traditional power and a design based on CEP. We show that if there is uncertainty in the study parameters and a distribution of plausible values for π 1 and π 2, the performance of the CEP design is more consistent and robust than traditional designs based on point estimates for the study parameters. Traditional sample size calculations based on point estimates for the hypothesized study parameters tend to underestimate the required sample size needed to account for the uncertainty in the parameters. The greatest marginal benefit of the proposed method is achieved when the uncertainty in the parameters is not large. CONCLUSIONS: Through this procedure, we are able to formally integrate prior information on the uncertainty and variability of the study parameters into the design of the study while maintaining a frequentist framework for the final analysis. Solving for the sample size that is necessary to achieve a high level of CEP given the available prior information helps protect against misspecification of hypothesized treatment effect and provides a substantiated estimate that forms the basis for discussion about the study's feasibility during the design phase.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ciarleglio MM, Arendt CD. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure. Trials. 2017. PMID: 28231813. doi:10.1186/s13063-017-1791-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。